Raised urinary glucocorticoid and adrenal androgen precursors in the urine of young hypertensive patients: Possible evidence for partial glucocorticoid resistance

Heart

Volumn 86, Issue 2, 2001, Pages 139-144

  Shamim, W ^a   Yousufuddin, M ^a   Francis, D P ^a   Gualdiero, P ^a   Honour, J W ^b   Anker, S D ^a   Coats, A J S ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Cortisol metabolites; Glucocorticoid receptor resistance; Glucocorticoid resistance; Premature hypertension

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANDROGEN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HORMONE PRECURSOR; HYDROCORTISONE; POTASSIUM; SODIUM;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE RESISTANCE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; SEX DIFFERENCE; SODIUM RETENTION; STEROID URINE LEVEL; URINARY EXCRETION; WATER RETENTION;

EID: 0034780982     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.86.2.139     Document Type: Article

References (53)

1. Prevalence of hypertension in the US adult population: Results from the Third National Health and Nutrition Examination Survey, 1988-1991
2. Secondary hypertension in a blood pressure clinic
3. Hypertension in family practice
4. The effect of age on prevalence of secondary forms of hypertension in a blood pressure clinic
5. Refractory hypertension
6. Abnormalities of glucocorticoid metabolism and the renin-angiosystem: A four-corner approach to the identification of genetic determinants of blood pressure
7. Hypertensive mechanisms associated with centrally administered aldosterone in dogs
8. Intracerebroventricular infusion of aldosterone induces hypertension in rats
9. Differential central effects of mineralocorticoid, and glucocorticoid agonists and antagonists on blood pressure
10. Brain corticosteroid receptors and central cardiovascular control
11. Effect of chronic intracerebroventricular dexamethasone on blood pressure in normotensive rats
12. 19-Norcorticosteroids in health, in hypertensive states in humans including 17 alpha-hydroxylase deficiency and in the spontaneously hypertensive rat (SHR)
13. Impaired cortisol binding to glucocorticoid receptors in hypertensive patients
14. Spontaneous hypercortisolism without Cushing's syndrome
15. Primary cortisol resistance in man. A glucocorticoid receptor-mediated disease
16. Elevated 18 hydroxycorticosterone in inbred salt sensitive rats
17. Primary cortisol resistance: A family study
18. A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion
19. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol
20. Consistent sex differences in cortisol response to psychological stress
21. Sex-dependent alteration in cortisol response to endogenous adrenocorticotropin
22. Blood pressure monitoring outside the office for the evaluation of patients with resistant hypertension
23. Validity and usefulness of non invasive ambulatory blood pressure monitoring
24. Blood pressure during normal daily activities, sleep and exercise
25. Left ventricular mass and geometry in patients with established hypertension and white-coat hypertension
26. Average daily blood pressure, not office pressure, determines cardiac function in patients with hypertension
27. Prognostic value of ambulatory blood pressure measurements: Further analysis
28. Ambulatory blood pressure: An independent predictor of prognosis in essential hypertension
29. Prognostic value of 24-hour blood pressure variability
30. Ambulatory blood pressure monitoring: Validation of the accuracy and reliability of the TM-2420 according to the AAMI recommendations
31. Simultaneous estimation of urinary steroids by semi-automated gas chromatography. Investigation of neo-natal infants and children with abnormal steroid synthesis
32. Steroid profiling
33. Hypertension and virilization caused by a unique desoxycorticosterone- and androgen-secreting adrenal adenoma
34. Diagnosis and treatment of 17-hydroxylase deficiency
35. Congenital adrenal hyperplasia: Molecular genetics and alternative approaches to treatment
36. Urinary free cortisone and the assessment of 11 β-hydroxysteroid dehydrogenase activity in man
37. Genetic, biochemical, and clinical studies of patients with A328V or R213C mutations in 11 β-HSD2 causing apparent mineralocorticold excess
38. Elevated urinary excretion of 18-oxocortisol in glucocorticold suppressible aldosteronism
39. A chimaeric 11 betahydroxylase/aldosterone ynthase gene causes glucocorticoid-remediable aldosteronism and human hypertension
40. Hereditary hypertension, caused by chimaeric gene duplications and ectopic expression of aldosterone synthase
41. Molecular basis of human hypertension: Role of angiotensinogen
42. Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity
43. Liddles's syndrome: Heritable human hypertension caused by mutations in the B subunit of the epithelial sodium channel
44. Hypertension caused by a truncated epithelial sodium channel gamma subunit: Genetic heterogeneity of Liddle's syndrome
45. A denovo missense mutation of the beta sub unit of the epithelial sodium channel causes hypertension and Liddle's syndrome and identifies a proline-rich segment of the protein critical for regulation of channel activity
46. Liddle's disease caused by a missense mutation of beta subunit of the epithelial sodium channel gene
47. Increased urinary cortisol and androgen metabolites in a young female with hypertension: Partial glucocorticoid resistance syndrome
48. When is cortisol a mineralocorticoid?
49. Primary glucocorticoid receptor defect with likely familial involvement
50. Cortisol receptor resistance: The variability of its clinical presentation and response to treatment
51. Glucocorticoid physiology, pharmacology and stress
52. Syndromes of glucocorticoid resistance
53. Syndromes of glucocorticoid and mineralocorticoid resistance